Orphan Drugs

Advances for patients with rare diseases

Drugs for the treatment of rare diseases are referred to as “orphan drugs.” Rare diseases are defined as conditions that affect 5 or fewer in 10,000 people residing in an all country.

In recent years, there have been many innovations to improve the treatment options for the affected patients.

Please contact with Pacific Pharma directly if you already have a prescription for a drug.

If that is not the case, please contact your doctor to discuss the options of such a treatment.

Pacific Pharma is a core supplier specialized in the provision of pharmaceuticals and medical supplies in an international basis. Established in 2002 with the goal of expanding its service to a global scale. Pacific Pharma is now an integral part of the market and supplying to 73 countries in 5 continents with its robust service network.

Latest news

Copyright by Pacific Pharma 2017. All rights reserved.